522 results on '"Shiohara T"'
Search Results
2. 470 Regulatory T cells act either by expansion at the acute phase or by steep contraction at the resolution phase in severe drug eruptions
3. Pompholyx as a clinical manifestation suggesting increased serum IgG levels in a patient with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms
4. Herpes simplex virus reactivation as a trigger of mucous lesions in pemphigus vulgaris
5. Elevated serum thymus and activation-regulated chemokine (TARC/CCL17) relates to reactivation of human herpesvirus 6 in drug reaction with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS)
6. The dynamics of herpesvirus reactivations during and after severe drug eruptions: their relation to the clinical phenotype and therapeutic outcome
7. International Consensus on drug allergy
8. Supportive care in the acute phase of Stevens–Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary Delphi‐based consensus
9. Comment on ‘Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID‐19’: involvement of herpesvirus reactivations and adverse drug reactions in diverse cutaneous manifestations and overall disease severity of COVID‐19
10. Commentary on “The risk of anti‐osteoporotic agent‐induced severe cutaneous adverse drug reactions and their association with HLA” by W‐H Chunget al
11. Varicella-zoster virus antigen expression of eccrine gland and duct epithelium in herpes zoster lesions
12. COVID‐19‐related cutaneous manifestations associated with multiple drug sensitization as shown by lymphocyte transformation test
13. Differences in immunological alterations and underlying viral infections in two well-defined severe drug eruptions
14. Nonpigmenting fixed drug eruption as a possible abortive variant of toxic epidermal necrolysis: immunohistochemical and serum cytokine analyses
15. Distribution of T serotypes of group A streptococci isolates from cellulitis lesions
16. Risk factors for severe impetiginized atopic dermatitis in Japan and assessment of its microbiological features
17. In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption
18. Syndrome of inappropriate secretion of antidiuretic hormone associated with limbic encephalitis in a patient with drug-induced hypersensitivity syndrome
19. Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption
20. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations
21. Sclerodermoid graft-versus-host disease-like lesions occurring after drug-induced hypersensitivity syndrome
22. The Importance of the Timing of the Lymphocyte Transformation Test Performed During the Evolution of the Disease
23. Drug-Induced Hypersensitivity Syndrome is a Manifestation of Newly Observed Immune Reconstitution Inflammatory Syndrome
24. Neuromedin U is the Principal Mediator of Hapten-Induced, TLR2-Dependent Mast Cell Activation that can be Inhibited by IgE and Scratching
25. Dramatic improvement of psoriatic erythroderma after acute hepatitis: analysis of cytokine synthesis capability in peripheral blood T cells
26. Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease
27. Gamma-Delta T Cells with Emphasis on Their Functional Role in the Epidermis
28. Homing receptor and chemokine receptor on intraepidermal T cells in psoriasis vulgaris
29. Which term should be used to describe drug eruptions confined to sites of previous herpes zoster lesions, ‘isotopic response’ or ‘recall phenomenon’?
30. Ebastine inhibits T cell migration, production of Th2-type cytokines and proinflammatory cytokines
31. Preferential expression of αEβ7 integrin (CD103) on CD8+ T cells in the psoriatic epidermis: regulation by interleukins 4 and 12 and transforming growth factor-β
32. Protective and curative effects of topically applied CX-659S, a novel diaminouracil derivative, on chronic picryl chloride-induced contact hypersensitivity responses
33. Propolis-induced granulomatous contact dermatitis accompanied by marked lymphadenopathy
34. The cytokine profile in a transient variant of angioedema with eosinophilia
35. Increased circulating skin-homing cutaneous lymphocyte-associated antigen (CLA)+ type 2 cytokine-producing cells, and decreased CLA+ type 1 cytokine-producing cells in atopic dermatitis
36. Porokeratosis in patients with hepatitis C virus infection: does hepatitis C virus infection provide a link between porokeratosis and immunosuppression?
37. Two Cases of Acute Febrile Neutrophilic Dermatosis Thought to be Caused by Topical Clindamycin
38. T cell receptor (TCR) repertoire and function of human epidermal T cells: restricted TCR VαVβ genes are utilized by T cells residing in the lesional epidermis in fixed drug eruption
39. Photolocalized eruption associated with acute hepatitis B virus infection
40. Varicella zoster virus as a possible trigger for the development of pityriasis lichenoides et varioliformis acuta: retrospective analysis of our institutional cases
41. 557 Influence of programmed cell death-1 immune checkpoint blockade on T cell profile and response to melanoma-associated antigen in advanced malignant melanoma patients
42. 260 Identification of early predictors of the efficacy of intravenous corticosteroid pulse therapy in rapidly-progressive diffuse alopecia areata patients
43. Lichen amyloidosus as a sweat gland/duct-related disorder: resolution associated with restoration of sweating disturbance
44. Pretreatment with topical glucocorticosteroids to enhance the antitumour efficacy of imiquimod: long-term follow-up in Bowen disease
45. 7th Drug hypersensitivity meeting: part two
46. Comment on 'Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID‐19': involvement of herpesvirus reactivations and adverse drug reactions in diverse cutaneous manifestations and overall disease severity of COVID‐19
47. International Consensus on drug allergy
48. Longitudinal analysis of antibody profiles against plakins in severe drug eruptions: emphasis on correlation with tissue damage in drug-induced hypersensitivity syndrome and drug reaction with eosinophilia and systemic symptoms
49. Synergistic Effects of Mycoplasma pneumoniae Infection and Drug Reaction on the Development of Atypical Stevens-Johnson Syndrome in Adults
50. Effect of orally administered aromatic retinoid on murine Langerhans cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.